These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32625199)

  • 1. A Novel Pathogenic Variant in
    Yonkof JR; Gupta A; Rueda CM; Mangray S; Prince BT; Rangarajan HG; Alshahrani M; Varga E; Cripe TP; Abraham RS
    Front Immunol; 2020; 11():884. PubMed ID: 32625199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CARMIL2 Immunodeficiency with Epstein Barr Virus Associated Smooth Muscle Tumor (EBV-SMT). Report of a Case with Comprehensive Review of Literature.
    Vij M; Sivasankaran M; Jayaraman D; Sankaranarayanan S; Kumar V; Munirathnam D; Scott J
    Fetal Pediatr Pathol; 2022 Dec; 41(6):1023-1034. PubMed ID: 34738861
    [No Abstract]   [Full Text] [Related]  

  • 3. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.
    Lévy R; Gothe F; Momenilandi M; Magg T; Materna M; Peters P; Raedler J; Philippot Q; Rack-Hoch AL; Langlais D; Bourgey M; Lanz AL; Ogishi M; Rosain J; Martin E; Latour S; Vladikine N; Distefano M; Khan T; Rapaport F; Schulz MS; Holzer U; Fasth A; Sogkas G; Speckmann C; Troilo A; Bigley V; Roppelt A; Dinur-Schejter Y; Toker O; Bronken Martinsen KH; Sherkat R; Somekh I; Somech R; Shouval DS; Kühl JS; Ip W; McDermott EM; Cliffe L; Ozen A; Baris S; Rangarajan HG; Jouanguy E; Puel A; Bustamante J; Alyanakian MA; Fusaro M; Wang Y; Kong XF; Cobat A; Boutboul D; Castelle M; Aguilar C; Hermine O; Cheminant M; Suarez F; Yildiran A; Bousfiha A; Al-Mousa H; Alsohime F; Cagdas D; Abraham RS; Knutsen AP; Fevang B; Bhattad S; Kiykim A; Erman B; Arikoglu T; Unal E; Kumar A; Geier CB; Baumann U; Neven B; ; Rohlfs M; Walz C; Abel L; Malissen B; Marr N; Klein C; Casanova JL; Hauck F; Béziat V
    J Exp Med; 2023 Feb; 220(2):. PubMed ID: 36515678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency.
    Kolukisa B; Baser D; Akcam B; Danielson J; Bilgic Eltan S; Haliloglu Y; Sefer AP; Babayeva R; Akgun G; Charbonnier LM; Schmitz-Abe K; Kendir Demirkol Y; Zhang Y; Gonzaga-Jauregui C; Jimenez Heredia R; Kasap N; Kiykim A; Ozek Yucel E; Gok V; Unal E; Pac Kisaarslan A; Nepesov S; Baysoy G; Onal Z; Yesil G; Celkan TT; Cokugras H; Camcioglu Y; Eken A; Boztug K; Lo B; Karakoc-Aydiner E; Su HC; Ozen A; Chatila TA; Baris S
    Allergy; 2022 Mar; 77(3):1004-1019. PubMed ID: 34287962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus
    Magg T; Schober T; Walz C; Ley-Zaporozhan J; Facchetti F; Klein C; Hauck F
    Front Immunol; 2018; 9():368. PubMed ID: 29535735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human immunodeficiency syndrome caused by mutations in CARMIL2.
    Schober T; Magg T; Laschinger M; Rohlfs M; Linhares ND; Puchalka J; Weisser T; Fehlner K; Mautner J; Walz C; Hussein K; Jaeger G; Kammer B; Schmid I; Bahia M; Pena SD; Behrends U; Belohradsky BH; Klein C; Hauck F
    Nat Commun; 2017 Jan; 8():14209. PubMed ID: 28112205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.
    Alazami AM; Al-Helale M; Alhissi S; Al-Saud B; Alajlan H; Monies D; Shah Z; Abouelhoda M; Arnaout R; Al-Dhekri H; Al-Numair NS; Ghebeh H; Sheikh F; Al-Mousa H
    Front Immunol; 2018; 9():203. PubMed ID: 29479355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.
    Bosa L; Batura V; Colavito D; Fiedler K; Gaio P; Guo C; Li Q; Marzollo A; Mescoli C; Nambu R; Pan J; Perilongo G; Warner N; Zhang S; Kotlarz D; Klein C; Snapper SB; Walters TD; Leon A; Griffiths AM; Cananzi M; Muise AM
    Sci Rep; 2021 Mar; 11(1):5945. PubMed ID: 33723309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
    Shamriz O; Simon AJ; Lev A; Megged O; Ledder O; Picard E; Joseph L; Molho-Pessach V; Tal Y; Millman P; Slae M; Somech R; Toker O; Berger M
    Clin Exp Immunol; 2020 Jun; 200(3):215-227. PubMed ID: 32201938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report.
    Zamani R; Zoghi S; Shahkarami S; Seyedpour S; Jimenez Heredia R; Boztug K; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2024; 24(5):596-605. PubMed ID: 37855284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells.
    Roncagalli R; Cucchetti M; Jarmuzynski N; Grégoire C; Bergot E; Audebert S; Baudelet E; Menoita MG; Joachim A; Durand S; Suchanek M; Fiore F; Zhang L; Liang Y; Camoin L; Malissen M; Malissen B
    J Exp Med; 2016 Oct; 213(11):2437-2457. PubMed ID: 27647348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.
    Kurolap A; Eshach Adiv O; Konnikova L; Werner L; Gonzaga-Jauregui C; Steinberg M; Mitsialis V; Mory A; Nunberg MY; Wall S; Shaoul R; Overton JD; ; Shuldiner AR; Zohar Y; Paperna T; Snapper SB; Shouval DS; Baris Feldman H
    J Clin Immunol; 2019 May; 39(4):430-439. PubMed ID: 31079270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential founder variant in
    Sorte HS; Osnes LT; Fevang B; Aukrust P; Erichsen HC; Backe PH; Abrahamsen TG; Kittang OB; Øverland T; Jhangiani SN; Muzny DM; Vigeland MD; Samarakoon P; Gambin T; Akdemir ZH; Gibbs RA; Rødningen OK; Lyle R; Lupski JR; Stray-Pedersen A
    Mol Genet Genomic Med; 2016 Nov; 4(6):604-616. PubMed ID: 27896283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited TNFSF9 deficiency causes broad Epstein-Barr virus infection with EBV+ smooth muscle tumors.
    Fournier B; Hoshino A; Bruneau J; Bachelet C; Fusaro M; Klifa R; Lévy R; Lenoir C; Soudais C; Picard C; Blanche S; Castelle M; Moshous D; Molina T; Defachelles AS; Neven B; Latour S
    J Exp Med; 2022 Jul; 219(7):. PubMed ID: 35657354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature.
    Petrilli G; Lorenzi L; Paracchini R; Ubiali A; Schumacher RF; Cabassa P; Facchetti F
    Int J Surg Pathol; 2014 Dec; 22(8):712-21. PubMed ID: 21454372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.
    Wang Y; Ma CS; Ling Y; Bousfiha A; Camcioglu Y; Jacquot S; Payne K; Crestani E; Roncagalli R; Belkadi A; Kerner G; Lorenzo L; Deswarte C; Chrabieh M; Patin E; Vincent QB; Müller-Fleckenstein I; Fleckenstein B; Ailal F; Quintana-Murci L; Fraitag S; Alyanakian MA; Leruez-Ville M; Picard C; Puel A; Bustamante J; Boisson-Dupuis S; Malissen M; Malissen B; Abel L; Hovnanian A; Notarangelo LD; Jouanguy E; Tangye SG; Béziat V; Casanova JL
    J Exp Med; 2016 Oct; 213(11):2413-2435. PubMed ID: 27647349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
    Magg T; Shcherbina A; Arslan D; Desai MM; Wall S; Mitsialis V; Conca R; Unal E; Karacabey N; Mukhina A; Rodina Y; Taur PD; Illig D; Marquardt B; Hollizeck S; Jeske T; Gothe F; Schober T; Rohlfs M; Koletzko S; Lurz E; Muise AM; Snapper SB; Hauck F; Klein C; Kotlarz D
    Inflamm Bowel Dis; 2019 Oct; 25(11):1788-1795. PubMed ID: 31115454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus-Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma.
    Wah NW; Mok Y; Omar N; Chang KTE; Tay TKY; Hue SS; Lee VKM
    Mod Pathol; 2023 Jun; 36(6):100127. PubMed ID: 36965331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-associated smooth muscle tumor of the cavernous sinus: a delayed complication of allogenic peripheral blood stem cell transplantation: case report.
    Raheja A; Sowder A; Palmer C; Rodriguez FJ; Couldwell WT
    J Neurosurg; 2017 May; 126(5):1479-1483. PubMed ID: 27341041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.
    Winter S; Martin E; Boutboul D; Lenoir C; Boudjemaa S; Petit A; Picard C; Fischer A; Leverger G; Latour S
    EMBO Mol Med; 2018 Feb; 10(2):188-199. PubMed ID: 29282224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.